You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
1 November 2023
Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000
5 January 2023
Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer
2 November 2022
Reset Pharmaceuticals announces appointment of neuroscience industry leader Lisa Deschamps to the Board of Directors